Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1988-05-04
1989-01-17
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514275, 514333, 514338, 514397, 514443, 5142282, 544146, 544295, 5142338, 544296, 544297, 544357, 544405, 546270, 548336, 549 50, A61K 3138, C07D49502, C07D40300, C07D42100
Patent
active
047988312
ABSTRACT:
Thieno[2,3-b]furan-2-sulfonamides are carbonic anhydrase inhibitors useful in the treatment of elevated intraocular pressure and glaucoma.
REFERENCES:
patent: 3733322 (1973-05-01), Wright
patent: 4668697 (1987-05-01), Shepard et al.
Kvitko et al., J. Org. Chem. (USSR) 12, 1550 (1976).
Halczenko Wasyl
Hartman George D.
Prugh John D.
Merck & Co. , Inc.
Nicholson William H.
Siegel Alan
Sudol, Jr. Michael C.
LandOfFree
Substituted thieno[2,3-B]furan-2-sulfonamides as antiglaucoma ag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted thieno[2,3-B]furan-2-sulfonamides as antiglaucoma ag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted thieno[2,3-B]furan-2-sulfonamides as antiglaucoma ag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2413625